Kelly Henning MD, has led the Bloomberg Philanthropies Public Health program since its inception in 2007. She is a medical doctor and epidemiologist trained in internal medicine, infectious diseases, and public health.
Projects under her direction include the Bloomberg Initiative to Reduce Tobacco Use, a 10-year global project aimed at curbing the tobacco epidemic in low– and middle-income countries; the Obesity Prevention Program, a three-year effort to support public health policies at reducing obesity in Mexico; the Bloomberg Global Road Safety Program, a 10-year commitment to reducing road traffic deaths and injuries in developing countries; the Bloomberg Maternal Health Program, a reproductive health initiative based in Africa; the Drowning Prevention Program, which tests high-potential interventions to prevent drowning deaths for children in Bangladesh and the Philippines; and the Data for Health initiative which will enable 20 low- and middle-income countries to vastly improve public health data collection.
Prior to joining Bloomberg Philanthropies, Henning was an Associate Professor of Infectious Diseases and Hospital Epidemiology at the University of Pennsylvania School Of Medicine. From 2003-2006, she served as Director of the newly formed Division of Epidemiology at the New York City Department of Health and Mental Hygiene.
Henning received her medical degree from Tufts University School of Medicine and a fellowship in Infectious Diseases at Memorial Sloan-Kettering Cancer Center. She completed Internal Medicine training at the University of Pennsylvania and received her Epidemiology training in the Epidemic Intelligence Service at the United States Centers for Disease Control and Prevention.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.